Given the high expression levels of ofCS and EpCAM, and the relatively low expression of PD-L1 and EGFR, the combination of rVAR2 and EpCAM was chosen for optimal targeting and enrichment of NSCLC cells. This evidence concerns the gene EPCAM and non-small cell lung carcinoma.